Why the Lester Lab-in-the-Bag?

Slides:



Advertisements
Similar presentations
Early Intervention in Psychosis... Dec 7 th Wakefield
Advertisements

Professor Jo Smith, Consultant Clinical Psychologist and EI Lead
HEALTH, WELLNESS AND LONGEVITY INITIATIVE Magellan Health Services of Arizona Clinical Initiatives.
Self-management intervention to prevent weight gain in young patients with antipsychotic medication Johan Åhlin, Sonja Beckmann, Indre Brasaite Loreena.
Level Health Equally Well Key findings from a literature review informing collaborative efforts to improve the physical health outcomes of people with.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
The Contribution of Mental Health Services to Tackling Health Inequalities Dr Alastair Cook Chair RCPsych in Scotland.
Metabolic effects Diabetes
Professor Julia Hippisley-Cox University of Nottingham.
Physical health assessment and monitoring in long-term mental health care Dr Alan Farmer Consultant Psychiatrist Worcestershire Mental Health Partnership.
Improving the Quality of Physical Health Checks
Improving the Quality of Physical Health Checks Kate Dale, Mental/Physical Health Lead BDCT.
Health priorities for Charnwood, 2010 and beyond Dr Mike McHugh Consultant in Public Health NHS Leicestershire County and Rutland 7/9/10.
Managing Psychosis (NICE Guidelines 2014)
VA/DoD 2006 Clinical Practice Guideline For Screening and Management of Overweight and Obesity Guideline Summary: Key Elements.
Simon Belderbos Consultant Psychiatrist
Integrating Behavioral Health and Primary Care
“People with serious mental illnesses (like schizophrenia and bipolar disorder) die, on average, 20 years earlier than the rest of the population”. Rethink,
STEPWISE: STructured lifestyle Education for People WIth SchizophrEnia Chris Dickens, Professor of Psychological Medicine University of Exeter Medical.
Teresa Hudson, PharmD Center for Mental Healthcare and Outcomes Research South Central Mental Illness Research Education and Clinical Center.
Monitoring Physical Health Stephen R. Marder, M.D. Professor, Semel Institute for Neuroscience and Human Behavior at UCLA Director, VA VISN 22 Mental Illness.
The Poor Health Status of Consumers of Mental Health Care: Prevalence, Quality of Care and Cost for Persons with SMI and Diabetes Brenda Harvey, Commissioner.
Health & Wellbeing in Oldham Alan Higgins Director of Public Health Oldham.
Diabetes Research Network Professor Azeem Majeed Imperial College, London.
Chapter Metabolic Syndrome Peterson and Gordon C H A P T E R.
Cardiovascular Risk: A global perspective
Section 1: Introduction Dr Somen Banerjee, Director of Public Health London Borough Tower Hamlets.
POMH-UK Topic 2e supplementary audit Screening for metabolic side effects of antipsychotic drugs in patients under the care of assertive outreach teams.
The introduction of a routine offer of relapse prevention pharmacotherapy following successful alcohol withdrawal: A quality improvement project in a 20.
Primary care and population health management
Prevention Diabetes.
C Wilson, KM Rhodes, RA Payne
DR GHULAM NABI KAZI WHO Country Office Pakistan
Development and Implementation of a Tobacco Cessation Toolkit
Title of the Change Project
Seema Jain1, Rebecca Andridge2, Jessica Hellings3
Antipsychotic Prescribing
The Poor Health Status of Consumers of Mental Health Care: Prevalence, Quality of Care and Cost for Persons with SMI and Diabetes Brenda Harvey, Commissioner.
Better Monitoring for Better Health
Noncommunicable diseases
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults Risks and Assessment NHLBI Obesity Education.
Ageing with ideal cardiovascular risk factors
Prevention Cardiovascular disease
Treatments for psychosis; how the NHS has pioneered new research and service models to improve outcomes. Paul French.
Parity of Esteem People with mental health conditions will receive the same quality of physical healthcare as their peers. Marie Band Physical Health lead.
2016/17 Commissioning Intentions Angela Wright
Contribution to closing the financial gap:
Consultant Psychiatrist and Research Fellow, IoPPN.
Information for Network Providers
A cluster randomised controlled trial testing an intervention to lower cardiovascular disease risk for people with severe mental illnesses in primary care.
2016/17 Commissioning Intentions Angela Wright
Prevention Diabetes Dr Abir Youssef 29/11/2018.
Here are a several research articles that focus on the intersection between ACES and obesity These articles could be embedded into slide decks to underscore.
Effective and humane care for all with mental, neurological,
1 Physical Activity, Health, and Chronic Disease chapter 1 chapter
First Episode Psychosis: National Standards awareness for Primary Care
Although adverse childhood events may account for only a small proportion of the current obesity epidemic in the U.S. (Alvarez et al., 2007), risk of obesity.
NCD – Kingdom of Saudi Arabia
1. Reduce harms from the main preventable causes of poor health
Our people die too soon, too often
High Blood Pressure in General Practice: Variation and Opportunities South Cheshire CCG (v11) 5th March 2019.
Increasing Investment in Prevention in Wales, The Journey So Far
Cardiovascular Disease in Women Module III: Risk Assessment Tool
Anna Cowell James O’Connell Aintree Weight Management Team
How will the NHS Long Term Plan work in our community?
High Risk of Heart Disease in South Asians
Certified Community Behavioral Health Clinic
Dr Timothy Armstrong Coordinator
Base Case Behavior for 1990–2040
High Blood Pressure and Risk Factors in Young Population: How to Manage Ayrton Pires Brandão Associate Professor of Cardiology - State University of.
Presentation transcript:

Why the Lester Lab-in-the-Bag? for People Experiencing Psychosis Professor Paul French: Associate Director Greater Manchester Mental Health NHS FT, Early Intervention in Psychosis lead NHSE North Dr David Shiers: former GP North Staffordshire, honorary reader in Early Psychosis, Manchester Univ Cromwell House February 24th 2017 e: david.shiers@doctors.org.uk Early Intervention in psychosis NSF mental health policy implementation RADICAL UPSTREAM YOUTH FOCUSED INTENSIVE COMMUNITY-BASED NOW  MOST YP WITH P CAN ACCESS EIS IN ENGLAND  LESS CRISIS, MORE PROACTIVE EBM INTERVENITIONS WHICH ARE AGE AND PPHASE SPECIFIC DECREASING TURMOIL OF FEP UNDERSTANDABLE FOCUS HOWEVER I  ATTENTION TO ANISSUE WHICH MAY GET OVERLOOKED – IMPACT OF P ON DOWNSTREAM PHYSICAL HEALTH 25YRS LOSS OF EXPECTANCY – GREATER CONTRIBUTION TO THESE PREMATURE DEATHS FROM PHYSICAL EXPLANATIONS THAN FROM SUICIDE MY HOPE IS YOU WILL TAKE AWAY TO KEEP BODY IN MIOND NEXT TIME YOU SEE A YP WITH A DIAGNOSIS OF PSYCHOSIS IN YOUR SURGERY

Dame Professor Sue Bailey 2013 2016 The fact that people with severe mental illness die twenty years earlier than the rest of the population, the majority from preventable causes, is one of the biggest health scandals of our time, yet is very rarely talked about. Dame Professor Sue Bailey

12 kg 4 kg kg Months 3 kg First episode of psychosis RCTs Figure 1. ANTIPSYCHOTIC-INDUCED WEIGHT GAIN IN CHRONIC AND FIRST-EPISODE PSYCHOTIC DISORDERS: A SYSTEMATIC CRITICAL REAPPRAISAL 20 Established Psychosis RCTs Established psychosis RCTs 3 kg 15 4 kg kg 10 12 kg 5 First episode of psychosis RCTs 12 24 Months 36 48 Published with permission from Dr Mario Alvarez-Jimenez. Data from Alvarez-Jimenez et al; CNS Drugs, 2008 22: 547-562

Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial CINP 2012 doi:10.1017/S1461145712001241 Fleischhacker WW, Siu CO, Bode R, Pappadopulos E, Karayal ON, Kahn RS, and the EUFEST study group Overall baseline prevalence of metabolic syndrome was 6.0%, with similar rates observed in the antipsychotic-naive patients (5.7%) and in the other patients with only a brief prior exposure to antipsychotics (6.1%).

...on a path to obesity, type 2 diabetes, cardiovascular disease and premature death METABOLIC SYNDROME Central obesity Insulin resistance Dyslipidemia Hypertension + SMOKING Metabolic Syndrome is a clinical concept whose presence predicts higher rates of CVD and type 2 diabetes The primary abnormality is an abnormal waist circumference This may drive the other abnormalities listed

Relative to gen population CVD Risk Factor SCHIZOPHRENIA BIPOLAR DISORDER Rate Relative to gen population Smoker 50-80% 2-3x 54-68% Obese 45-55% 2x 21-49% 1-2x Physically inactive 70% 1.5-2x Hypertension 19-58% 35-61% Type 2 diabetes 10-15% 8-17% 1.5-3x Lipid disturbances 25-69% ≤5x 23-38% ≤3x Adapted from De Hert et al (2011) Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry, 10: 52-77 And Lindamer et a (2008) Assessment of physical activity in middle-aged and older adults with schizophrenia. Schizophr Res, 104: 294-301 l

“The provision of good medical care tends to vary inversely with the need for it in the population served.” Julian Tudor Hart Glyncorrwg 1971

www.rcpsych.ac.uk/quality/NAS/resources UK intervention framework launch 2012, update 2014 Collaborative approach to tackling CVD and T2 diabetes risks in any service setting. Supported by key Royal Colleges Rethink Mental Illness, Faculty of Public Health, Diabetes UK Core of NHSE CQUINs 2014/19 www.rcpsych.ac.uk/quality/NAS/resources

Glucose and lipid disturbances DON’T JUST SCREEN… Smoking Poor diet & inactivity Glucose and lipid disturbances Hypertension Poor prescribing

2013-15 DON’T SCREEN, INTERVENE JUST 2013: NICE guideline CG 155 Children and young people experiencing psychosis and schizophrenia 2014: NICE guideline CG 178 Adults experiencing psychosis and schizophrenia 2015: NICE Quality Standard 80 www.rcpsych.ac.uk/quality/NAS/resources Mention iphYs development and NSW health support